Despite this, the use of DNASE1 as a diagnostic or prognostic biomarker in cancer remains unique, as does its relationship with other immune cells such as macrophages, CD8+ T cells, dendritic cells, and neutrophils. This evidence concerns the gene DNASE1 and cancer.